Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
12 | -0.181 | -41.9953596288 | 0.431 | 0.59 | 0.23 | 13571 | 0.37912088 | DE |
26 | -0.32 | -56.1403508772 | 0.57 | 0.89 | 0.22 | 31059 | 0.52241993 | DE |
52 | -2.69 | -91.4965986395 | 2.94 | 5.32 | 0.22 | 52273 | 0.9812052 | DE |
156 | -6.25 | -96.1538461538 | 6.5 | 11 | 0.22 | 19222 | 1.51909869 | DE |
260 | 0.093 | 59.2356687898 | 0.157 | 11 | 0.142 | 60031 | 1.2473815 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約